This is a test for the presence of antibodies to the Hepatitis C which is responsible for over 90% of hepatitis from blood transfusion. However, most cases of Hepatitis C (96%) is transmitted from intravenous drug use. Recombinant immunoblot assay (RIBA) detects antibodies to four HCV antigens.